Stromal cell protein kinase C-ß inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance. (2020)

First Author: Park E
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aax9340

PubMed Identifier: 31941829

Publication URI: http://europepmc.org/abstract/MED/31941829

Type: Journal Article/Review

Volume: 12

Parent Publication: Science translational medicine

Issue: 526

ISSN: 1946-6234